Clinical Trial Update: Autologous Polyclonal Tregs for Lupus [Phase 1]

View source ↗

Summary

Phase 1 trial update of autologous polyclonal T regulatory cells for lupus; study terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Erythematosus Cutaneous
• Lupus Erythematosus Discoid
• Lupus Erythematosus Systemic

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid | Phase 1 | Status: TERMINATED | Results posted: 2019-11-12